价格

Recombinant Mycobacterium Tuberculosis

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Recombinant protein capable of resisting multiple sclerosis and preparation method and application thereof
US 12734224 B2申请人: INST OF ZOOLOGY GUANGDONG ACADEMY OF SCIENCES优先权: 2021
CN
US
WO
4 件公开
MODIFIED BCG VACCINE
EP 4642479 A1申请人: UNIV JOHANNESBURG WITWATERSRAND优先权: 2023
CN
EP
WO
3 件公开
CONSTRUCTION METHOD OF RECOMBINANT DRUG-RESISTANT MYCOBACTERIUM BOVIS BACILLUS CALMETTE-GUERIN (BCG) STRAIN AND PHARMACEUTICAL COMPOSITION FOR TREATING TUBERCULOSIS (TB)
US 2022387575 A1申请人: GUANGZHOU INST BIOMED & HEALTH优先权: 2020
CN
US
3 件公开
Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
US 7244613 B2申请人: PASTEUR INSTITUT优先权: 2001
US
3 件公开
MYCOBACTERIUM TUBERCULOSIS (Mtb) ADENOSINE TRIPHOSPHATE (ATP) SYNTHASE-EXPRESSING RECOMBINANT BACTERIUM, AND CONSTRUCTION METHOD AND EXPRESSION METHOD THEREOF
US 20240360459 A1申请人: UNIV NANKAI优先权: 2023
CN
US
2 件公开
RECOMBINANT MYCOBACTERIUM AS A VACCINE IN THE PREVENTION OF TUBERCULOSIS OCCURRENCE AND RECURRENCE
EP 4763219 A1申请人: SERUM INST OF INDIA PRIVATE LIMITED优先权: 2024
EP
WO
2 件公开
Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state
US 7935354 B2申请人: AERAS GLOBAL TB VACCINE FOUNDATION优先权: 2007
US
2 件公开
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
- US 7670609 B2
  申请人: AERAS GLOBAL TB VACCINE FOUND优先权: 2007
  US
  2 件公开
- US 8361482 B2
  申请人: AERAS GLOBAL TB VACCINE FOUND优先权: 2009
  US
  2 件公开
RECOMBINANT STRAIN OF MYCOBACTERIUM BOVIS BACILLUS CALMETTE-GUERIN (BCG), IMMUNOGENIC COMPOSITION AND USE
US 2015152145 A1申请人: FUNDACAO BUTANTAN优先权: 2012
US
2 件公开
Recombinant mycobacterium tuberculosis fusion protein EMC and preparation method thereof
CN 120173131 A申请人: BEIJING YUANYI TONGHE BIOTECHNOLOGY CO LTD优先权: 2024
CN
2 件公开

药物

Recombinant Mycobacterium Tuberculosis

专利

Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease